Novo Nordisk A/S (NVO)

35.29
0.17 0.48
NYSE : Health Care
Prev Close 35.46
Open 35.21
Day Low/High 35.20 / 35.45
52 Wk Low/High 30.89 / 57.81
Volume 1.93M
Avg Volume 3.12M
Exchange NYSE
Shares Outstanding 2.55B
Market Cap 90.42B
EPS 2.00
Div & Yield 1.33 (3.70%)

Latest News

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

NVO INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Novo Nordisk A/S

NVO INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Novo Nordisk A/S

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Novo Nordisk A/S ("Novo...

NVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Novo Nordisk A/S And A Lead Plaintiff Deadline Of March 13, 2017

NVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Novo Nordisk A/S And A Lead Plaintiff Deadline Of March 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Novo Nordisk A/S (NYSE: NVO) securities between April...

Novo Nordisk Slumps on Disappointing Profit, Guidance Cut

Novo Nordisk Slumps on Disappointing Profit, Guidance Cut

Novo Nordisk shares slumped after the world's largest diabetes drug maker reported disappointing fourth-quarter operating profits due to price pressure and increased competition in the U.S.

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Novo Nordisk A/S Investors And Encourages Investors To Contact The Firm

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Novo Nordisk A/S Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO)...

NVO LOSS NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors Of Important Deadline In Class Action - NVO

NVO LOSS NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors Of Important Deadline In Class Action - NVO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Novo Nordisk A/S securities (NYSE:NVO) from April 30, 2015 through October 27, 2016, inclusive (the "Class Period") of the important March 13, 2017...

SHAREHOLDER ALERT: CLASS PERIOD EXPANDED IN CLASS ACTION LAWSUIT - Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact Brower Piven Before The Lead Plaintiff Deadline

SHAREHOLDER ALERT: CLASS PERIOD EXPANDED IN CLASS ACTION LAWSUIT - Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact Brower Piven Before The Lead Plaintiff Deadline

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

A Seismic Shift in Stock Picking: Cramer's 'Mad Money' Recap (Thursday 1/12/17)

A Seismic Shift in Stock Picking: Cramer's 'Mad Money' Recap (Thursday 1/12/17)

Amazon.com has all the qualities we really want from our stocks - now, says Jim Cramer.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Novo Nordisk A/S - NVO

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Novo Nordisk A/S - NVO

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Novo Nordisk A/S securities (NYSE:NVO) from April 30, 2015 through October 27, 2016, inclusive...

Stocks Off Session Lows as Pressure on Tech Shares and Financials Eases

Stocks Off Session Lows as Pressure on Tech Shares and Financials Eases

Wall Street comes off session lows by mid-afternoon Thursday as pressure on tech, health care and financial stocks eases.

Stocks at Session Lows as Tech, Drugmaker Names Sell Off

Stocks at Session Lows as Tech, Drugmaker Names Sell Off

The Nasdaq pulls back from a record high on Thursday as tech and drugmaker shares decline.

Stock Futures Hold Lower as Jobless Claims, Import Prices Rise

Stock Futures Hold Lower as Jobless Claims, Import Prices Rise

Stock futures hold lower on Thursday after weekly jobless claims rise and import prices climb.

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

Demographic trends that boosted big gains in prior years haven't gone away.

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.

Stop Listening to 'The Market'

Stop Listening to 'The Market'

Here are stocks with solid fundamentals at some of the best absolute entry points in years.

Novo Nordisk Is an Opportunity

Novo Nordisk Is an Opportunity

I bought the stock too early, but I am adding more.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AXE, CECE, EMN, FC, NNI, PDCO, SAH, SAMG, WERN Downgrades: ATW, CERN, IPXL, NVO, OMCL, PHII, PHIIK, PLKI, SVT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

One World Trade Center To Glow Blue In Honor Of World Diabetes Day Tonight

One World Trade Center To Glow Blue In Honor Of World Diabetes Day Tonight

The American Diabetes Association, JDRF, The New York Stem Cell Foundation Research Institute and Novo Nordisk Inc. Unite in the Battle Against Diabetes

MannKind Is Still Too Heavy to Avoid the Afrezza Crash Landing

MannKind Is Still Too Heavy to Avoid the Afrezza Crash Landing

MannKind bulls -- the rainbow-hued unicorns of the investment world -- believe the company's marketing efforts will succeed. They're wrong.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Stock futures are tumbling Wednesday but are well off their lows as Republican Donald Trump is elected the next president of the United States in a surprising victory.

TheStreet Quant Rating: C (Hold)